Novo Nordisk to Cut US Insulin Prices

Novo Nordisk to Cut US Insulin Prices
Image copyright: npr

The Spin

Narrative A

Novo Nordisk wants to do right by its customers. It’s taken some time to formulate a plan that makes insulin more affordable for patients and keeps the company competitive while it deals with changes in US laws. Diabetes patients can rest assured Novo Nordisk’s insulin products will always be affordable.

Narrative B

Novo Nordisk’s decision is a major win for insulin uses, but there are still plenty of price reductions that need to be made. It’s inexcusable that the US is an outlier when it comes to the high cost of insulin, and it’s time for Sanofi, another major insulin maker, to follow suit and reduce its prices.


Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!